Tert-butyl 4-(2-(4-chloro-2-ureidophenoxy)acetyl)piperidine-1-carboxylate → HCID 68586604, compound
Reaction equation
[Cl:1][C:2]1[CH:24]=[CH:23][C:5]([O:6][CH2:7][C:8]([CH:10]2[CH2:15][CH2:14][N:13](C(OC(C)(C)C)=O)[CH2:12][CH2:11]2)=[O:9])=[C:4]([NH:25][C:26]([NH2:28])=[O:27])[CH:3]=1>C(Cl)Cl.C(O)(C(F)(F)F)=O>[Cl:1][C:2]1[CH:24]=[CH:23][C:5]([O:6][CH2:7][C:8](=[O:9])[CH:10]2[CH2:15][CH2:14][NH:13][CH2:12][CH2:11]2)=[C:4]([NH:25][C:26]([NH2:28])=[O:27])[CH:3]=1Participants
4
Reactant 1
Product 1
Reagents, catalysts & solvents 2
Procedure
A sample of tert-butyl 4-(2-(4-chloro-2-ureidophenoxy)acetyl)piperidine-1-carboxylate (264 mg, 0.64 mmol) was dissolved in CH2Cl2 (8 mL) and TFA (4 mL). The resultant homogeneous solution was stirred for 3 h and concentrated in vacuo. The resultant residue was partitioned between EtOAc and sat. NaHCO3. The phases were separated and the aqueous phase was basified to pH˜14 (paper) with 1N NaOH before being extracted with EtOAc (twice). The organic extracts were combined, washed with brine, dried (Na2SO4), filtered, and concentrated in vacuo to afford 1-(5-chloro-2-(2-oxo-2-(piperidin-4-yl)ethoxy)phenyl)urea. LC/MS [M+H]+=312.07, [M+Na]+=334.04.
Workup
- concentrationconcentrated in vacuo
- customThe resultant residue was partitioned between EtOAc and sat. NaHCO3
- customThe phases were separated
- extractionbefore being extracted with EtOAc (twice)
- washwashed with brine
- dry with materialdried (Na2SO4)
- filtrationfiltered
- concentrationconcentrated in vacuo
Sources & evidence
- ORD record
- ord-10ee7f36ac8c43f2b38dc6ed460cdaf3
- Source dataset
- uspto-grants-2012_12
- Patent number
- US08324251B2
Reaction notes
Loading…